A detailed history of Victory Capital Management Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 28,724 shares of ADMA stock, worth $321,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,724
Previous 29,192 1.6%
Holding current value
$321,134
Previous $131,000 44.27%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$4.4 - $6.74 $2,059 - $3,154
-468 Reduced 1.6%
28,724 $189,000
Q4 2023

Feb 05, 2024

BUY
$3.08 - $4.52 $16,832 - $24,701
5,465 Added 23.03%
29,192 $131,000
Q3 2023

Nov 06, 2023

BUY
$3.47 - $4.61 $2,904 - $3,858
837 Added 3.66%
23,727 $84,000
Q2 2023

Jul 27, 2023

SELL
$3.12 - $4.22 $1,662 - $2,249
-533 Reduced 2.28%
22,890 $84,000
Q1 2023

May 02, 2023

BUY
$3.01 - $3.87 $70,503 - $90,647
23,423 New
23,423 $77,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.2B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.